Onconetix, Inc.
ONCO
$0.94
-$0.01-1.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -92.92% | -0.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -92.92% | -0.03% | |||
| Cost of Revenue | -58.68% | 60.63% | |||
| Gross Profit | -100.69% | -7.88% | |||
| SG&A Expenses | 35.52% | -35.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.33% | -33.20% | |||
| Operating Income | -63.24% | 38.07% | |||
| Income Before Tax | -174.33% | 164.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -174.34% | 164.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -174.34% | 164.55% | |||
| EBIT | -63.24% | 38.07% | |||
| EBITDA | -63.26% | 38.14% | |||
| EPS Basic | -137.10% | 157.84% | |||
| Normalized Basic EPS | -71.24% | 1,024.22% | |||
| EPS Diluted | -137.10% | 157.84% | |||
| Normalized Diluted EPS | -71.24% | 1,024.22% | |||
| Average Basic Shares Outstanding | 100.32% | 11.74% | |||
| Average Diluted Shares Outstanding | 100.32% | 11.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||